Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Total Non-current Assets
All assets not expected to be converted to cash within one year.
Total Non-current Assets history
Currency unavailable · from the balance sheet
No Total Non-current Assets data reported for this period type.
Total Non-current Assets vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ORKAOruka Therapeutics, Inc. | Sep 2026 | $289.53M USD | +87.9% | +621.1% | 23.5% |
| Mar 2026 | $88.49M USD | -0.9% | -26.6% | 44.5% | |
| Jun 2026 | $78.4M USD | -32.1% | +167.0% | 8.9% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $46.53M USD | -50.2% | +155.6% | 8.3% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €32.62M EUR | — | — | 19.7% |
| Mar 2026 | $13.58M USD | -77.0% | -55.7% | 4.1% | |
| Mar 2026 | $983K USD | -36.2% | -14.4% | 0.5% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -34.1% | +70.6% | 8.6% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.